UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Obesity Solutions for Patients over 65 Years of Age: Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric Surgery — International Survey Study

Dowgiallo-Gornowicz, Natalia; Wityk, Mateusz; Jaworski, Pawel; Lech, Pawel; Parmar, Chetan; (2025) Obesity Solutions for Patients over 65 Years of Age: Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric Surgery — International Survey Study. Obesity Surgery , 35 (8) pp. 3182-3189. 10.1007/s11695-025-08026-w. Green open access

[thumbnail of Obesity Solutions for Patients over 65 Years of Age Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric.pdf]
Preview
Text
Obesity Solutions for Patients over 65 Years of Age Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric.pdf - Published Version

Download (868kB) | Preview

Abstract

Introduction: The rising prevalence of obesity among the elderly poses unique challenges. While life expectancy has improved due to advancements in medical care, this increase in longevity does not necessarily correlate with an improved quality of life. Instead, the obesity epidemic, particularly in the later decades of life, is linked to a heightened demand for healthcare services and higher healthcare costs. This study aimed to analyze bariatric surgeons’ perspectives on the role of anti-obesity medications (AOMs) in metabolic bariatric surgery (MBS) for patients over 65, focusing on treatment preferences in clinical scenarios. Additionally, an obesity treatment algorithm for older patients was proposed. // Material and Methods: A survey was conducted among bariatric surgeons worldwide from September to October 2024, including questions on demographics, experience, and clinical scenarios. A questionnaire specifically designed for the purposes of this study was used. // Results: Of 184 respondents from 53 countries, 77.2% reported prescribing AOMs. Sleeve gastrectomy is most preferred as the primary surgical option for patients over 65. Treatment preferences varied by BMI, with AOMs favored for a BMI of 30–35 kg/m2, and MBS preferred for higher BMIs. // Conclusions: This study highlights the integration of AOMs into obesity management for older adults, with sleeve gastrectomy as the primary surgical choice. Treatment choices were consistent across surgeon demographics, underscoring the need for tailored approaches in elderly obesity care.

Type: Article
Title: Obesity Solutions for Patients over 65 Years of Age: Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric Surgery — International Survey Study
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s11695-025-08026-w
Publisher version: https://doi.org/10.1007/s11695-025-08026-w
Language: English
Additional information: This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Keywords: Metabolic bariatric surgery; Anti-obesity medications; GLP-1 receptor agonists; GLP-1; Elderly; Sleeve gastrectomy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention
URI: https://discovery.ucl.ac.uk/id/eprint/10215390
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item